Results of Using Combined Oral Contraceptives with Drospirenone and Finasteride in Women with Polycystic Ovary Syndrome Without Metabolic Disorders

    January 2011 in “ Practical medicine ”
    Н. Н. Захарова, С. А. Дворянский
    TLDR Both finasteride and drospirenone treatments improved symptoms and increased pregnancy rates in women with polycystic ovary syndrome.
    The study surveyed 113 women with polycystic ovary syndrome without metabolic abnormalities, dividing them into two groups: 58 received finasteride (5 mg) and 55 received combined oral contraceptives with drospirenone (3 mg) over 6 months. Both treatments showed a pronounced therapeutic effect. After treatment, 7 pregnancies occurred in the finasteride group and 8 in the drospirenone group, indicating a rebound effect in reproductive function.
    Discuss this study in the Community →